News
FDA, recall
Digest more
The recalls have been classified as Class II, where the probability of serious adverse health consequences is remote.
As Department of Health and Human Services (HHS) and FDA leadership continue to look for ways to boost transparency and ...
The United States Food and Drug Administration (FDA) has suspended the license for Valneva's chikungunya vaccine Ixchiq with ...
Valneva must immediately cease U.S. shipments and sales of Ixchiq, a vaccine for chikungunya virus. The FDA recently lifted a ...
The FDA said it has begun publishing reports of adverse events concerning drugs on a daily basis, instead of quarterly, as it ...
A detail of a packaging of the Ixchiq chikungunya vaccine, in a pharmacy in Saint-Denis, La Réunion, is shown March 21. The ...
FDA delays Axogen's Avance Nerve Graft BLA review to December 5, after new data submission, while the company raises its full ...
A new Wisconsin law will to ban non-FDA approved vape products will go into effect on September 1st of Labor Day Weekend.
By Stephanie Brown HealthDay ReporterMONDAY, Aug. 25, 2025 (HealthDay News) -- The U.S. Food and Drug Administration is ...
The Food and Drug Administration approved Papzimeos (zopapogene imadenovec-drba) for the treatment of adults with recurrent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results